CPSI Names Wes Cronkite as New Chief Innovation Officer
Key Role to Help Company Reach Adjacent Markets Through Innovation MOBILE, Ala.--(BUSINESS WIRE)--CPSI (NASDAQ: CPSI), a community healthcare solutions company,...
News
Elucid Secures $8 Million in Series A Funding Led by MedTex Ventures and Global Health Impact Fund
Industry Veterans Join Executive Leadership Team to Empower Next Stage of Company Growth BOSTON--(BUSINESS WIRE)--Elucid, a medical technology company developing...
CLS Holdings USA, Inc. to Present at the Canaccord Genuity 2021 Virtual Cannabis Conference
LAS VEGAS, NV / ACCESSWIRE / May 10, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the ''Company'' or ''CLS'', a...
Halberd Corp. Designated as a BREAKOUT Stock to Watch in Investor Publications
JACKSON CENTER, PA / ACCESSWIRE / May 10, 2021 / Halberd Corporation (OTC PINK:HALB) was recently discussed in Penny Stocks News...
Asia Green Biotechnology Corp. and InPlanta Biotechnology Ltd. Announce Grant of Full Registration of “Bountiful” Hemp Cultivar
CALGARY, AB / ACCESSWIRE / May 10, 2021 / Asia Green Biotechnology Corp. ("Asia Green" or the "Company") (CSE:ASIA) announced...
Co-CEOs Robert Groesbeck and Larry Scheffler Convert All of Their Class A Restricted Voting Shares of Planet 13 Holdings Inc. Into Common Shares
LAS VEGAS, NV / ACCESSWIRE / May 10, 2021 / Planet 13 Holdings Inc. ("Planet 13") (CSE:PLTH)(OTCQX:PLNHF), a leading vertically-integrated...
Sonnet BioTherapeutics Completes Successful GLP Repeat Dose Toxicology Study of IL12-FHAB (SON-1010) in Non-Human Primates (NHP)
The No Observed Adverse Event Level (NOAEL) following repeated administration was more than 50 times the anticipated equivalent human clinical...
Generex Posts Recording of May 6 Shareholder Conference Call Highlighting its Ii-Key COVID Complete Vaccine™ and its Go-Forward Plans for Revenue Producing Assets
Update on Ii-Key-SARS-CoV-2 vaccine programAppointment of Dr. Craig Eagle to be Chairman of the Board of NuGenerex Immuno-Oncology Inc. pending...
Kymera Therapeutics Presents Late-Breaking Preclinical Data on IRAK4 Degrader KT-474 at IMMUNOLOGY2021™ Annual Meeting
New in vivo data demonstrate the broad anti-inflammatory activity of KT-474 and its superiority compared to a clinically active small...
Surgalign Submits Premarket Notification 510(k) of Its Digital Surgical Guidance System
Augmented Reality and Artificial Intelligence Technology Acquired Via Holo Surgical AcquisitionDEERFIELD, Ill., May 10, 2021 (GLOBE NEWSWIRE) -- Surgalign Spine Technologies...
ATEC to Virtually Participate in the Canaccord Genuity Musculoskeletal Conference
CARLSBAD, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative spine surgery solutions...
Stereotaxis Reports 2021 First Quarter Financial Results
ST. LOUIS, May 10, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the...
Cassava Sciences Announces Initiation of Cognition Maintenance Study in Alzheimer’s disease
- Randomized, Controlled Study is Designed to Evaluate Cognition in Patients Who Continue Versus Discontinue Simufilam Over Six Months – -...
Yield10 Bioscience to Participate at the Benzinga Global Small Cap Conference on May 14, 2021
WOBURN, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced that...
Gennao Bio Closes $40 Million Series A Financing to Develop Pipeline of Targeted Nucleic Acid Therapeutics
~ Financing Co-led by OrbiMed and Logos Capital to Support Advancement of Proprietary Gene Monoclonal Antibody Platform (GMAB) ~ ~...
Eyenovia Announces New $25 Million Credit Facility with Silicon Valley Bank
NEW YORK, May 10, 2021 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a...
Chiesi Group calls for #ActionOverWords in the fight against climate change
Chiesi Group, the largest international pharmaceutical company Certified B Corporation™, reinforces 2035 carbon neutral target with #ActionOverWords campaign to encourage...
Vaxcyte Announces Publication of Preclinical Data Supporting the Potential of VAX-24 for the Prevention of Invasive Pneumococcal Disease
VAX-24 is a 24-Valent Broad-Spectrum Pneumococcal Conjugate Vaccine Leveraging Vaxcyte’s Technology PlatformFOSTER CITY, Calif., May 10, 2021 (GLOBE NEWSWIRE) --...
RVL Pharmaceuticals Upneeq® Wins 2021 MedTech Breakthrough Award
Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and CompaniesBRIDGEWATER, N.J., May 10, 2021 (GLOBE NEWSWIRE) -- RVL...
INDUSTRY SOURCE CONSULTING PROVIDES MARKET REPORTS AS IT MOVES FORWARD WITH NEW BUSINESS STRATEGY
Thomasville, GA, May 10, 2021 (GLOBE NEWSWIRE) -- Industry Source Consulting, Inc. (OTC: INSO), reported today that it has submitted...